Takeda and Protagonist Therapeutics have jointly submitted a NDA seeking approval from the US FDA for rusfertide to treat ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

With a $25 million grant from PCORI, the Penn team will launch a randomized controlled trial to see if their game reduces the ...

Soleno Therapeutics (SLNO) announced a publication in the peer-reviewed Journal of Clinical Endocrinology and Metabolism. The paper, titled, ...

Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

HUTCHMED has commenced the Phase III stage of its ongoing Phase II/III clinical trial assessing the combination of ...

Suicide is the second or third leading cause of death for youth. Most suicidal youth are seen by professionals and referred ...

Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...

Research shows that matcha's impressive nutritional profile of antioxidants (and more) can support weight loss; however, it’s ...

A study published earlier this year in the Journal of Neuro-Oncology indicates that sonodynamic therapy (SDT) safely destroys GBM cells while preserving healthy brain tissue. Using a noninvasive ...

Negative symptoms of schizophrenia affect motivation, emotion, and daily life. Learn the signs, why they’re often missed, and ...

This scoping review identifies the first wave of randomized controlled trials testing large language models in digestive diseases. Four published and ten ongoing trials suggest that AI tools such as ...